Cargando…
C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling
Renal osteodystrophy (ROD) occurs as early as chronic kidney disease (CKD) stage 2 and seems ubiquitous in almost all pediatric patients with CKD stage 5. Fibroblast growth factor (FGF)-23, a bone-derived endocrine regulator of phosphate homeostasis, is overexpressed in CKD and disturbs osteoblast d...
Autores principales: | Zhang, Dong Dong, Wu, Yang Fang, Chen, Wei Xia, Xu, Yao, Liu, Si Yan, Luo, Huang Huang, Jiang, Guang Mei, Wu, Yue, Hu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802631/ https://www.ncbi.nlm.nih.gov/pubmed/31263178 http://dx.doi.org/10.1038/s12276-019-0265-8 |
Ejemplares similares
-
FGF23(C-tail) improves diabetic nephropathy by attenuating renal fibrosis and inflammation
por: Zhang, Xiaomin, et al.
Publicado: (2018) -
Bone Canopies in Pediatric Renal Osteodystrophy
por: Pereira, Renata C., et al.
Publicado: (2016) -
Cyst-like Tumors in Renal Osteodystrophy
por: Li Cavoli, Gioacchino, et al.
Publicado: (2021) -
Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23
por: Ng, Nicholas Beng Hui, et al.
Publicado: (2022) -
Prevalence of Renal Osteodystrophy in African Hemodialysis Patients
por: Bahad, Abdelaali, et al.
Publicado: (2013)